Abstract:
An organic light-emitting device including a magnetoresistive element including a first magnetic layer, a second magnetic layer, and a separation layer disposed between the first magnetic layer and the second magnetic layer, an organic light-emitting element electrically connected to the magnetoresistive element, wherein the organic light-emitting element comprises a first electrode, a second electrode, and an organic light-emission layer disposed between the first electrode and the second electrode, a magnetic field applying unit configured to apply a magnetic field to at least the magnetoresistive element, and optionally, to the organic light-emitting element, a power source configured to supply a current between the magnetoresistive element and the organic light-emitting element, and a current source configured to apply a current between both terminals of the organic light-emitting element, wherein light-emission characteristics of the organic light-emitting device are changed depending on a direction and intensity of a current passing through the magnetoresistive element due to the power source and a direction and intensity of a current passing through the organic light-emitting element due to the power source and the current source.
Abstract:
An organometallic compound represented by Formula 1: M(L1)n1(L2)n2 Formula 1 wherein in Formula 1, M in Formula 1 is selected from iridium (Ir), platinum (Pt), osmium (Os), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), thulium (Tm), and rhodium (Rh), L1 in Formula 1 is selected from a ligand represented by Formula 2A or 2B as they are defined in the specification, and L2 in Formula 1 is selected from a mono-anionic organic ligand.
Abstract:
An organometallic compound represented by Formula 1: wherein in Formula 1, groups and variables are the same as described in the specification.
Abstract:
A chemical compound is provided having a structure that includes at least one donor moiety covalently bonded to at least one acceptor moiety. For example, the compound may include an indolocarbazole moiety covalently bonded to at least one furylpyridine moiety. The compound may exhibit thermally activated delayed fluorescence and an accompanying ΔEST of no greater than about 0.25 eV. The compound finds use in OLED display technology.
Abstract:
An organometallic compound represented by Formula 1: M(L1)n1(L2)n2, Formula 1 wherein M is selected from iridium (Ir), platinum (Pt), osmium (Os), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), thulium (Tm), and rhodium (Rd), and wherein L1 is a ligand represented by Formula 2A and L2 is a ligand represented by Formula 2B, and wherein L1 and L2 in Formula 1 are different from each other,
Abstract:
An organometallic compound represented by Formula 1, an organic light-emitting device including the same, and a diagnostic composition including the organometallic compound: wherein, Formula 1, R1 to R12 and R21 to R23 are each independently the same as described in the detailed description of the specification.
Abstract:
An organometallic compound represented by Formula 1: M(L1)n1(L2)n2 Formula 1 In Formula 1, M is a transition metal; L1 is a ligand represented by Formula 2 as disclosed herein; L2 is a monodentate ligand, a bidentate ligand, a tridentate ligand, or a tetradentate ligand; n1 is 1, 2, or 3, wherein, when n1 is 2 or greater, two or more ligands L1 are identical to or different from each other; n2 is 0, 1, 2, 3, or 4, wherein, when n2 is 2 or greater, two or more ligands L2 are identical to or different from each other; and L1 and L2 are different from each other.
Abstract:
An organometallic compound represented by Formula 1: Formula 1 M1(L1)n1(L2)n2 wherein M1 is a transition metal, L1 is a ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2: wherein Y1 is O, S, or Se; Z1 and Z2 are each independently —Si(Q1)(Q2)(Q3) or —Ge(Q1)(Q2)(Q3); a1 and a2 are each independently an integer from 0 to 10; a sum of a1 and a2 is 1 or greater; * and *′ each indicate a binding site to M1; and the descriptions of the remaining substituents in Formulae 1A and 1B are as provided herein.
Abstract:
An organometallic compound represented by Formula 1, wherein in Formula 1, groups and variables are the same as described in the specification.